CHICAGO — Baseline best corrected visual acuity, vitreous haze, OCT and other factors do not appear to have an impact on outcomes of patients who receive a fluocinolone acetonide intravitreal insert, according to a speaker here.
“The subgroup analysis shows us that the baseline status does not appear to impact the overall result and the rate of recurrence [of uveitis],” Quan Dong Nguyen, MD, said at the American Academy of Ophthalmology meeting.
The double-masked, prospective, sham-controlled study included 129 patients with noninfectious posterior uveitis who underwent 2:1
Uncategorized